About: covid:PMC7127548

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7127548 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Ilonen, Jorma Honkanen, Hanna Hoppu, Sanna Huhtala, Heini Hyöty, Heikki Knip, Mikael Seppälä, Elina Simell, Olli Viskari, Hanna
is schema:about of	named entity 'otitis media' named entity '8.2' named entity 'pathogens' named entity 'Finland' named entity 'antibody-mediated' named entity 'otitis media' named entity 'OPV' named entity 'Poisson regression' named entity 'polio' named entity 'virus infections' named entity 'Finland' named entity 'acute phase' named entity 'AOM' named entity 'Sabin' named entity 'polioviruses' named entity 'adenovirus' named entity 'Stata' named entity 'Sabin' named entity 'innate immune' named entity 'poliovirus' named entity 'vaccine' named entity 'influenza' named entity 'vaccine' named entity 'IPV' named entity 'Sabin' named entity 'viruses' named entity 'otitis media' named entity 'infection' named entity 'risk factors' named entity 'type 1 interferon' named entity 'OPV' named entity 'OPV' named entity 'antibody' named entity 'South America' named entity 'URI' named entity 'IPV' named entity 'Finland' named entity 'coronavirus' named entity 'cohort study' named entity 'RSV' named entity 'enteroviruses' named entity 'follow-up' named entity 'vaccination' named entity 'OPV' named entity 'poliovirus vaccine' named entity 'Finland' named entity 'C-type' named entity 'vaccine' named entity 'malignant disease' named entity 'antibiotic treatments' named entity 'etiology' named entity 'live attenuated' named entity 'Viruses' named entity 'rhinovirus' named entity 'OPV' named entity 'enterovirus' named entity 'OPV' named entity 'adenovirus' named entity '2.45' named entity 'multivariate analysis' named entity 'cross-react' named entity 'vaccine' named entity 'bacteria' named entity 'URIs' named entity 'follow-up' named entity 'Finnish' named entity 'enteroviruses' named entity 'immunodeficiency' named entity 'OPV' named entity 'Salk' named entity 'parainfluenza virus' named entity 'polio vaccines' named entity 'type 1 diabetes' named entity 'HLA class II' named entity 'long-lasting' named entity 'pneumococcal conjugate vaccine' named entity 'Picornaviruses' named entity 'epidemic' named entity 'newborn infants' named entity 'influenza' named entity 'live vaccine' named entity 'innate immune response' named entity 'AOM' named entity 'OPV' named entity 'OPV' named entity 'IPV' named entity 'OPV' named entity 'viruses' named entity 'polio' named entity 'live attenuated virus' named entity 'long-lasting'

Attributes

Values

Creator

Ilonen, Jorma
Honkanen, Hanna
Hoppu, Sanna
Huhtala, Heini
Hyöty, Heikki
Knip, Mikael
Seppälä, Elina
Simell, Olli
Viskari, Hanna

is schema:about of

named entity 'otitis media'
named entity '8.2'
named entity 'pathogens'
named entity 'Finland'
named entity 'antibody-mediated'
named entity 'otitis media'
named entity 'OPV'
named entity 'Poisson regression'
named entity 'polio'
named entity 'virus infections'
named entity 'Finland'
named entity 'acute phase'
named entity 'AOM'
named entity 'Sabin'
named entity 'polioviruses'
named entity 'adenovirus'
named entity 'Stata'
named entity 'Sabin'
named entity 'innate immune'
named entity 'poliovirus'
named entity 'vaccine'
named entity 'influenza'
named entity 'vaccine'
named entity 'IPV'
named entity 'Sabin'
named entity 'viruses'
named entity 'otitis media'
named entity 'infection'
named entity 'risk factors'
named entity 'type 1 interferon'
named entity 'OPV'
named entity 'OPV'
named entity 'antibody'
named entity 'South America'
named entity 'URI'
named entity 'IPV'
named entity 'Finland'
named entity 'coronavirus'
named entity 'cohort study'
named entity 'RSV'
named entity 'enteroviruses'
named entity 'follow-up'
named entity 'vaccination'
named entity 'OPV'
named entity 'poliovirus vaccine'
named entity 'Finland'
named entity 'C-type'
named entity 'vaccine'
named entity 'malignant disease'
named entity 'antibiotic treatments'
named entity 'etiology'
named entity 'live attenuated'
named entity 'Viruses'
named entity 'rhinovirus'
named entity 'OPV'
named entity 'enterovirus'
named entity 'OPV'
named entity 'adenovirus'
named entity '2.45'
named entity 'multivariate analysis'
named entity 'cross-react'
named entity 'vaccine'
named entity 'bacteria'
named entity 'URIs'
named entity 'follow-up'
named entity 'Finnish'
named entity 'enteroviruses'
named entity 'immunodeficiency'
named entity 'OPV'
named entity 'Salk'
named entity 'parainfluenza virus'
named entity 'polio vaccines'
named entity 'type 1 diabetes'
named entity 'HLA class II'
named entity 'long-lasting'
named entity 'pneumococcal conjugate vaccine'
named entity 'Picornaviruses'
named entity 'epidemic'
named entity 'newborn infants'
named entity 'influenza'
named entity 'live vaccine'
named entity 'innate immune response'
named entity 'AOM'
named entity 'OPV'
named entity 'OPV'
named entity 'IPV'
named entity 'OPV'
named entity 'viruses'
named entity 'polio'
named entity 'live attenuated virus'
named entity 'long-lasting'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software